The aim of this study was to elucidate the expression and the prognostic role of CD133, CD166, CD44s, EpCAM, and ALDH1 expression in colorectal cancer, by using a tissue microarray including 1420 primary colorectal cancers with full clinicopathological data and follow-up. Here, ALCAM is linked to colorectal cancer.